1. Home
  2. SBFG vs BDSX Comparison

SBFG vs BDSX Comparison

Compare SBFG & BDSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SB Financial Group Inc.

SBFG

SB Financial Group Inc.

HOLD

Current Price

$23.01

Market Cap

136.9M

Sector

Finance

ML Signal

HOLD

Logo Biodesix Inc.

BDSX

Biodesix Inc.

HOLD

Current Price

$16.81

Market Cap

153.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SBFG
BDSX
Founded
1983
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Precision Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
136.9M
153.3M
IPO Year
2014
2020

Fundamental Metrics

Financial Performance
Metric
SBFG
BDSX
Price
$23.01
$16.81
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$32.50
AVG Volume (30 Days)
13.6K
43.5K
Earning Date
04-23-2026
05-04-2026
Dividend Yield
2.98%
N/A
EPS Growth
27.33
N/A
EPS
0.69
N/A
Revenue
N/A
$88,499,000.00
Revenue This Year
N/A
$25.26
Revenue Next Year
N/A
$19.15
P/E Ratio
$32.38
N/A
Revenue Growth
N/A
24.08
52 Week Low
$17.28
$0.26
52 Week High
$23.93
$20.21

Technical Indicators

Market Signals
Indicator
SBFG
BDSX
Relative Strength Index (RSI) 56.35 62.78
Support Level $20.94 $13.46
Resistance Level $23.93 $20.21
Average True Range (ATR) 0.76 1.00
MACD 0.05 0.01
Stochastic Oscillator 67.47 80.64

Price Performance

Historical Comparison
SBFG
BDSX

About SBFG SB Financial Group Inc.

SB Financial Group Inc that provides a range of community banking services, including commercial and consumer lending, personal and business banking, treasury management and merchant services, personal wealth management and brokerage services, and other financial services to individuals, businesses, and municipalities. It operates in a single segment, which is Banking.

About BDSX Biodesix Inc.

Biodesix Inc is a diagnostic solutions company with a focus on lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources: providing diagnostic testing services associated with blood-based lung and COVID tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties, as well as the development and commercialization of companion diagnostics.

Share on Social Networks: